List of insiders holdings for Oxford Immunotec Global PLC:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| STEINMETZ MICHAEL Director 10% Owner | 2013-11-22 17:32:51 | 0 2,579,062 | 2,579,062 | Form 3 |
| Lathi Vijay K Director 10% Owner | 2013-11-21 20:57:18 | 0 1,377,497 | 1,377,497 | Form 3 |
| Pitchford Nigel A. Director | 2013-11-21 20:12:14 | 0 833,448 | 833,448 | Form 3 |
| Altieri Richard M. Chief Financial Officer | 2019-01-03 16:30:32 | 207,965 0 | 207,965 | Form 4 |
| Linn Stefan C Chief Operating Officer | 2020-03-13 16:32:08 | 133,536 0 | 133,536 | Form 4 |
| Schroeder Jeff R. Chief Commercial Officer | 2017-05-10 16:30:19 | 127,147 0 | 127,147 | Form 4 |
| Edwardson Peter Chief Operations Officer | 2017-08-24 16:30:06 | 92,905 0 | 92,905 | Form 4/A |
| Wenstrup Richard Chief Medical Officer | 2018-03-19 17:12:44 | 42,104 0 | 42,104 | Form 4 |
| Keiley Elizabeth M SVP & General Counsel | 2019-03-06 16:30:40 | 26,928 0 | 26,928 | Form 4 |
| Spotts Stephen L Director | 2017-06-08 16:32:50 | 7457 0 | 7457 | Form 4 |
| ROSENMAN HERM Director | 2021-03-12 16:37:45 | 0 0 | 0 | Form 4 |
| McLaughlin Matthew T E Chief Financial Officer | 2021-03-12 16:37:19 | 0 0 | 0 | Form 4 |
| SANDBERG RICHARD A Director | 2021-03-12 16:36:57 | 0 0 | 0 | Form 4 |
| Klausner Mark R. Director | 2021-03-12 16:36:45 | 0 0 | 0 | Form 4 |
| RANDALL PATRICIA Director | 2021-03-12 16:36:14 | 0 0 | 0 | Form 4 |
| Kidd Janet Louise General Counsel | 2021-03-12 16:36:16 | 0 0 | 0 | Form 4 |
| Walton Andrew Scott Director | 2021-03-12 16:35:55 | 0 0 | 0 | Form 4 |
| BALTHROP PATRICK J Director | 2021-03-12 16:36:01 | 0 0 | 0 | Form 4 |
| Wrighton-Smith Peter Chief Executive Officer | 2021-03-12 16:35:55 | 0 0 | 0 | Form 4 |
| ANDREWS RONALD ASBURY Director | 2021-03-12 16:35:37 | 0 0 | 0 | Form 4 |
| TOBIN JAMES R Director | 2021-03-12 16:35:26 | 0 0 | 0 | Form 4 |
| New Leaf Ventures II L.P. New Leaf Venture Associates II L.P. New Leaf Venture Management II L.L.C. Chambon Philippe O. NIEDEL JAMES HUNT RONALD Delagardelle Jeani Ratcliffe Liam Former 10% Beneficial Owner Director | 2017-08-21 15:51:33 | 0 0 | 0 | Form 13G |
| Clarus Lifesciences I L.P. Clarus Ventures I Management L.P. Clarus Ventures I LLC GALAKATOS NICHOLAS HENNER DENNIS LIPTAK ROBERT Simon Nicholas WHEELER KURT 10% Owner | 2018-02-12 16:17:16 | 0 0 | 0 | Form 13G |